Sort
16,300 grants matching “fatty liver disease”
Metabolomic predictors of insulin resistance and diabetes
$680,498Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2021 · DK
Quantitative Ultrasound To Diagnose Nonalcoholic Fatty Liver Disease in Children.
$680,419Claude B Sirlin · University Of California, San Diego · R01 · FY2025 · DK
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
$680,226Donald A. McClain · Wake Forest University Health Sciences · R01 · FY2019 · DK
Developmental flame retardant exposure, gut microbiome, and obesity
$679,987Julia Yue Cui · University Of Washington · R01 · FY2024 · ES
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
$679,905Jonathan Q. Purnell · Oregon Health & Science University · R01 · FY2015 · DK
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
$679,734Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2025 · DK
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
$679,734Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2023 · DK
Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes
$679,731Tatyana Kushner · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$679,686Claude B Sirlin · University Of California, San Diego · R01 · FY2016 · DK
Neuroimaging predictors of bariatric surgical outcomes
$679,172Pavlos Papasavas · Hartford Hospital · R01 · FY2020 · DK
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway
$678,976Daniel James Rader · University Of Pennsylvania · R01 · FY2020 · HL
Mediators of Atherosclerosis in South Asians Living in America
$678,794Alka M Kanaya · University Of California, San Francisco · R01 · FY2016 · HL
Identification and functional impact of NAFLD associated genetic variants
$678,672Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2016 · DK
Metabolic Responses to an Oral Mixed Meal Tolerance Test: Intra-individual changes, correlates, and prognostic significance
$678,406Matthew G. Nayor · Boston University Medical Campus · R01 · FY2024 · HL
Lipid Nutrition and the Brain
$678,238Stanley I Rapoport · National Institute On Aging · ZIA · FY2011 · AG
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$678,171Brian Jesse Debosch · Washington University · R01 · FY2021 · HL
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$677,982Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · DK
Autoimmune Basis of Acquired Lipodystrophies
$677,951Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2025 · DK
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$677,927Danish Saleheen · Columbia University Health Sciences · R01 · FY2022 · DK
Living Cell Arrays for Real Time Functional Genomics
$677,573Martin L Yarmush · Massachusetts General Hospital · R01 · FY2007 · AI
Molecular Dissection of Scap
$677,369Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2017 · HL
Molecular Dissection of Scap
$677,369Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2019 · HL
Molecular Dissection of Scap
$677,369Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2021 · HL
Molecular Dissection of Scap
$677,369Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2020 · HL
Gluconeogenesis and Glycogenolysis - Role and Regulation
$677,102Dale S Edgerton · Vanderbilt University · R01 · FY2025 · DK